Serrulatane diterpenoids with unusual side chain modifications from root bark of Eremophila longifolia
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
Serrulatane diterpenoids with unusual side chain modifications from root bark of Eremophila longifolia. / Rasmussen, Line Fentz; Anton, Jennifer; Kjaerulff, Louise; Zhao, Yong; Semple, Susan J.; Ndi, Chi; Buirchell, Bevan; Møller, Birger Lindberg; Stærk, Dan.
I: Phytochemistry, Bind 203, 113408, 2022.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Serrulatane diterpenoids with unusual side chain modifications from root bark of Eremophila longifolia
AU - Rasmussen, Line Fentz
AU - Anton, Jennifer
AU - Kjaerulff, Louise
AU - Zhao, Yong
AU - Semple, Susan J.
AU - Ndi, Chi
AU - Buirchell, Bevan
AU - Møller, Birger Lindberg
AU - Stærk, Dan
PY - 2022
Y1 - 2022
N2 - The plant genus Eremophila is endemic to Australia and widespread in arid regions. Root bark extract of Eremophila longifolia (R.Br.) F.Muell. (Scrophulariaceae) was investigated by LC-PDA-HRMS, and dereplication suggested the presence of a series of diterpenoids. Using a combination of preparative- and analytical-scale HPLC separation as well as extensive 1D and 2D NMR analysis, the structures of 12 hitherto unreported serrulatane diterpenoids, eremolongine A-L, were established. These structures included serrulatanes with unusual side chain modifications to form hitherto unseen skeletons with, e.g., cyclopentane, oxepane, and bicyclic hexahydro-1H-cyclopenta[c]furan moieties. Serrulatane diterpenoids in Eremophila have recently been shown to originate from a common biosynthetic precursor with conserved stereochemical configuration, and this was used for tentative assignment of the relative and absolute configuration of the isolated compounds. Triple high-resolution α-glucosidase/α-amylase/PTP1B inhibition profiling demonstrated that several of the eremolongines had weak inhibitory activity towards targets important for management of type 2 diabetes.
AB - The plant genus Eremophila is endemic to Australia and widespread in arid regions. Root bark extract of Eremophila longifolia (R.Br.) F.Muell. (Scrophulariaceae) was investigated by LC-PDA-HRMS, and dereplication suggested the presence of a series of diterpenoids. Using a combination of preparative- and analytical-scale HPLC separation as well as extensive 1D and 2D NMR analysis, the structures of 12 hitherto unreported serrulatane diterpenoids, eremolongine A-L, were established. These structures included serrulatanes with unusual side chain modifications to form hitherto unseen skeletons with, e.g., cyclopentane, oxepane, and bicyclic hexahydro-1H-cyclopenta[c]furan moieties. Serrulatane diterpenoids in Eremophila have recently been shown to originate from a common biosynthetic precursor with conserved stereochemical configuration, and this was used for tentative assignment of the relative and absolute configuration of the isolated compounds. Triple high-resolution α-glucosidase/α-amylase/PTP1B inhibition profiling demonstrated that several of the eremolongines had weak inhibitory activity towards targets important for management of type 2 diabetes.
U2 - 10.1016/j.phytochem.2022.113408
DO - 10.1016/j.phytochem.2022.113408
M3 - Journal article
C2 - 36063865
VL - 203
JO - Phytochemistry
JF - Phytochemistry
SN - 0031-9422
M1 - 113408
ER -
ID: 316572366